Engineers Gate Manager’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$257K Buy
66,869
+16,691
+33% +$68.4K ﹤0.01% 1790
2025
Q4
$186K Buy
+50,178
New +$430K ﹤0.01% 1818
2024
Q2
Sell
-1,175
Closed -$39.1K 2154
2024
Q1
$39.1K Sell
1,175
-2,243
-66% -$114K ﹤0.01% 1816
2023
Q4
$277K Buy
+3,418
New +$278K 0.01% 1495
2022
Q3
Sell
-1,987
Closed -$443K 1954
2022
Q2
$443K Buy
1,987
+481
+32% +$207K 0.02% 1180
2022
Q1
$1.02M Buy
+1,506
New +$906K 0.04% 664

Other funds holding OM

Engineers Gate Manager's OM Position: Q1 2026 in Review

Engineers Gate Manager increased its Outset Medical (OM) stake by 33% in Q1 2026, buying an estimated $68.4K and bringing the position to 66,869 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #1790.

Engineers Gate Manager first reported a position in OM in Q1 2022 and has held it in 6 quarters since. The position peaked at $1.02M in Q1 2022. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Engineers Gate Manager held 66,869 shares of Outset Medical worth $257K as of Q1 2026.
  • Engineers Gate Manager bought 16,691 Outset Medical shares in Q1 2026, an estimated $68.4K.
  • Outset Medical made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1790 holding.
  • Engineers Gate Manager first reported a position in Outset Medical in Q1 2022 and has held it in 6 quarters since.
  • Engineers Gate Manager's Outset Medical position peaked at $1.02M in Q1 2022.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.